Evidence map›Paper›PMID 31688456›Full record

ReviewCurrent opinion in hematology2020

Transcription factor and cytokine regulation of eosinophil lineage commitment.

Ethan A Mack, Warren S Pear

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in hematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Emerging Roles of Eosinophils in Bone.Current osteoporosis reports · 2025
    Review
  7. Review
  8. Review
  9. Guided monocyte fate to FRβ/CD163Cellular and molecular life sciences : CMLS · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Eosinophils and Lung Cancer: From Bench to Bedside.International journal of molecular sciences · 2022
    Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ethan A MackDepartment of Pathology and Laboratory Medicine, Abramson Family Cancer Research Institute, Perelman School of Medicine at the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Warren S Pear
University of Pennsylvania · US

Funding

HEMATOLOGY CLINICAL RESEARCH TRAINING PROGRAMT32HL007439 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI LAWRENCE F BRASS, PETER S KLEIN · 1985 to 2026
$17.1M
Notch Regulation of Hematopoietic Cell FatesR01AI047833 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI JORDAN, MARTHA S, PEAR, WARREN S · 2000 to 2022
$7.4M
The role of Trib1 in granulocyte identity and activationF30HL136127 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MACK, ETHAN ANDREW · 2017 to 2018
$39k
NHLBI NIH HHS F30 HL136127NHLBI NIH HHS T32 HL007439NIAID NIH HHS R01 AI047833
6 · The paper itself

Abstract

purpose of reviewLineage commitment is governed by instructive and stochastic signals, which drive both active induction of the lineage program and repression of alternative fates. Eosinophil lineage commitment is driven by the ordered interaction of transcription factors, supported by cytokine signals. This review summarizes key findings in the study of eosinophil lineage commitment and examines new data investigating the factors that regulate this process. RECENT

findingsRecent and past studies highlight how intrinsic and extrinsic signals modulate transcription factor network and lineage decisions. Early action of the transcription factors C/EBPα and GATA binding protein-1 along with C/EBPε supports lineage commitment and eosinophil differentiation. This process is regulated and enforced by the pseudokinase Trib1, a regulator of C/EBPα levels. The cytokines interleukin (IL)-5 and IL-33 also support early eosinophil development. However, current studies suggest that these cytokines are not specifically required for lineage commitment. SUMMARY: Together, recent evidence suggests a model where early transcription factor activity drives expression of key eosinophil genes and cytokine receptors to prime lineage commitment. Understanding the factors and signals that control eosinophil lineage commitment may guide therapeutic development for eosinophil-mediated diseases and provide examples for fate choices in other lineages.

Indexed as

Signal TransductionCCAAT-Enhancer-Binding ProteinsEosinophilsGATA1 Transcription FactorHumansInterleukin-33Interleukin-5Intracellular Signaling Peptides and ProteinsProtein Serine-Threonine KinasesCCAAT-Enhancer-Binding ProteinsCEBPA protein, humanCEBPE protein, humanGATA1 protein, humanGATA1 Transcription FactorIL33 protein, humanIL5 protein, humanInterleukin-33Interleukin-5Intracellular Signaling Peptides and ProteinsProtein Serine-Threonine KinasesTRIB1 protein, human

Identifiers

PMID31688456
PMCPMC7388079
OpenAlexW2989368278

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.